We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.31B
AUM Growth
-$6.78M
(-0.16%)
Cap. Flow
-$84.5M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
17.08%
Holding
648
New
28
Increased
305
Reduced
288
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$9.05M |
| 2 |
Charter Communications
CHTR
|
+$8.12M |
| 3 |
S&P Global
SPGI
|
+$6.6M |
| 4 |
Liberty Global Class C
LBTYK
|
+$5.81M |
| 5 |
TE Connectivity
TEL
|
+$5.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$34.5M |
| 2 |
Altria Group
MO
|
+$27.9M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$13.2M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$9.85M |
| 5 |
Liberty Media Series C
FWONK
|
+$9.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.96% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.15% |
| 4 | Communication Services | 10.53% |
| 5 | Consumer Discretionary | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$195B
| $32.2M | 0.75% |
304,390
-23,633
| -7% | -$2.44M |
|
27
Bank of America
BAC
$429B
| $31.6M | 0.73% |
2,382,484
+9,698
| +0.4% | +$136K |
|
28
UnitedHealth
UNH
$384B
| $31M | 0.72% |
219,225
+1,681
| +0.8% | +$224K |
|
29
Oracle
ORCL
$345B
| $29.7M | 0.69% |
726,006
-2,976
| -0.4% | -$119K |
|
30
Citigroup
C
$214B
| $28.9M | 0.67% |
681,163
+1,125
| +0.2% | +$49.7K |
|
31
Bristol-Myers Squibb
BMY
$129B
| $28.2M | 0.65% |
383,594
+3,867
| +1% | +$273K |
|
32
Medtronic
MDT
$111B
| $28.1M | 0.65% |
324,209
+1,120
| +0.3% | +$90.6K |
|
33
Berkshire Hathaway Class B
BRK.B
$1.09T
| $27.1M | 0.63% |
187,297
+7,780
| +4% | +$1.11M |
|
34
Amgen
AMGN
$209B
| $26.2M | 0.61% |
172,469
+853
| +0.5% | +$133K |
|
35
Gilead Sciences
GILD
$166B
| $26.1M | 0.61% |
313,170
-14,602
| -4% | -$1.3M |
|
36
SLB Ltd
SLB
$73.3B
| $25.8M | 0.6% |
326,623
+35,308
| +12% | +$2.71M |
|
37
McDonald's
MCD
$192B
| $24.9M | 0.58% |
206,871
-2,335
| -1% | -$292K |
|
38
3M
MMM
$92.1B
| $24.4M | 0.57% |
166,328
+21,594
| +15% | +$3.04M |
|
39
CVS Health
CVS
$136B
| $23.7M | 0.55% |
247,516
-5,095
| -2% | -$508K |
|
40
AbbVie
ABBV
$465B
| $22.2M | 0.52% |
359,256
-12,786
| -3% | -$779K |
|
|
AGN
41
DELISTED
Allergan plc
AGN
| $21.1M | 0.49% |
91,179
+1,334
| +1% | +$308K |
|
42
Mastercard
MA
$498B
| $19.9M | 0.46% |
225,886
-243
| -0.1% | -$23.2K |
|
43
Starbucks
SBUX
$118B
| $19.5M | 0.45% |
341,694
+2,083
| +0.6% | +$118K |
|
44
Honeywell
HON
$76.6B
| $19.3M | 0.45% |
184,630
+1,567
| +0.9% | +$161K |
|
45
RTX Corp
RTX
$292B
| $18.9M | 0.44% |
293,522
-20,787
| -7% | -$1.33M |
|
46
Boeing
BA
$170B
| $18.8M | 0.44% |
144,700
-1,038
| -0.7% | -$135K |
|
47
Qualcomm
QCOM
$170B
| $18.5M | 0.43% |
345,660
+1,424
| +0.4% | +$75K |
|
48
Eli Lilly
LLY
$1.08T
| $18.2M | 0.42% |
230,594
+2,761
| +1% | +$208K |
|
|
WBA
49
DELISTED
Walgreens Boots Alliance
WBA
| $17.7M | 0.41% |
212,724
+14,250
| +7% | +$1.15M |
|
|
CELG
50
DELISTED
Celgene Corp
CELG
| $17.7M | 0.41% |
179,563
+941
| +0.5% | +$97.3K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q2 2016 Portfolio in Review
As of Q2 2016, Fjarde Ap-fonden held 648 positions worth $4.31B, down 0.16% from $4.32B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden's Q2 2016 filing shows 28 new, 305 increased, 288 reduced and 27 closed positions. Its largest new stake was NXP Semiconductors: 105,478 shares worth $8.26M. The largest sale was Philip Morris, an estimated $34.5M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Fjarde Ap-fonden's largest Q2 2016 buy was NXP Semiconductors: 105,478 shares worth $8.26M.
- Fjarde Ap-fonden added most to Charter Communications in Q2 2016, an estimated $8.12M increase.
- Fjarde Ap-fonden's biggest Q2 2016 reduction was Edgewell Personal Care, cutting an estimated $4.46M.
- Fjarde Ap-fonden fully exited Philip Morris in Q2 2016, selling an estimated $34.5M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.31B portfolio in Q2 2016.
- Fjarde Ap-fonden opened 28 new positions and closed 27 in Q2 2016.
- Fjarde Ap-fonden's portfolio value fell 0.16% quarter-over-quarter to $4.31B.
Based on Fjarde Ap-fonden's 13F filing for Q2 2016, filed 18 Aug 2016.